December 10, 2021
Life Sciences
  • The FDA authorized the Pfizer/BioNTech COVID-19 vaccine booster shots for people ages 16 and 17. Just as with adults, 16- and 17-year-olds are eligible to receive a booster dose six months after their second dose of the Pfizer/BioNTech vaccine. CDC Director Dr. Rochelle Walensky promptly approved the move and encouraged adolescents to receive a booster dose. (Articles here, here, here, here, and here)